Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Number of holders
-
252
-
Total 13F shares, excl. options
-
84,107,036
-
Shares change
-
-1,104,746
-
Total reported value, excl. options
-
$1,564,456,429
-
Value change
-
-$12,268,287
-
Put/Call ratio
-
36%
-
Number of buys
-
143
-
Number of sells
-
100
-
Price
-
$18.60
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2022
As of 31 Dec 2022 CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) had 252 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 84,107,036 shares of stock of the company.
Largest 10 holders included BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MILLENNIUM MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, TWO SIGMA INVESTMENTS, LP, TWO SIGMA ADVISERS, LP, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY.
This table shows 252 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.